Literature DB >> 26733419

The Clinicopathological Features and Long-Term Survival Outcomes of Mucinous Gastric Carcinoma: a Consecutive Series of 244 Cases from a Single Institute.

Xiaolong Tang1, Jianwei Zhang1, Xu Che1, Zhongmin Lan1, Yingtai Chen1, Chengfeng Wang2.   

Abstract

BACKGROUND AND OBJECTIVES: Mucinous gastric carcinoma (MGC) is a rare kind of malignancy with unclear prognosis. This study aims to assess the clinicopathological features and prognosis of MGC.
METHODS: We retrospectively analyzed a consecutive series of 244 MGC patients who underwent radical gastrectomy with D2 lymphadenectomy, and compared the data with 260 gastric signet ring cell carcinoma (SRC) patients.
RESULTS: The univariate survival analysis showed that the surgical types, diameter of the primary tumor, the Borrmann type, pathological depth of tumor invasion (pT), pathological number of metastatic lymph node (pN), pathological tumor lymph metastasis (pTNM), and vascular invasion were all significant predictors of survival (all P < 0.05). The multivariate survival analysis revealed that the diameter of the tumor, the Borrmann type, pT, pTNM stage, and vascular invasion as an independent predictive factor of survival (all P < 0.05). Compared with the SRC group, the MGC group had more male patients, more elder patients, larger tumor diameter, more T3 and T4 invasion to the gastric wall, more patients with metastatic lymph nodes, more pTNM stage III, and less Borrmann type 1. The overall survival rate of patients with MGC was significantly lower than that of patients with SRC (P < 0.001).
CONCLUSIONS: MGC was an aggressive malignancy which had unique clinicopathological features.

Entities:  

Keywords:  Gastric carcinoma; Mucinous carcinoma; Prognosis; Signet ring cell carcinoma; Surgery

Mesh:

Year:  2016        PMID: 26733419     DOI: 10.1007/s11605-015-3064-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  16 in total

Review 1.  Induction and regulation of epithelial-mesenchymal transitions.

Authors:  B Boyer; A M Vallés; N Edme
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

2.  Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma.

Authors:  Ming Zhang; Guan-yu Zhu; Hong-feng Zhang; Hong-yu Gao; Xiao-feng Han; Ying-wei Xue
Journal:  J Surg Oncol       Date:  2010-07-01       Impact factor: 3.454

3.  Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma.

Authors:  Zhaode Bu; Zhixue Zheng; Ziyu Li; Xiaojiang Wu; Lianhai Zhang; Aiwen Wu; Xianglong Zong; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

4.  Clinicopathologic characteristics of mucinous gastric adenocarcinoma.

Authors:  W J Hyung; S H Noh; D W Shin; C H Yoo; C B Kim; J S Min; K S Lee
Journal:  Yonsei Med J       Date:  1999-04       Impact factor: 2.759

5.  Clinicopathologic features of mucinous gastric carcinoma.

Authors:  Sang Woo Lim; L S Woo; D Y Kim; Y J Kim; S K Kim
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

6.  Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.

Authors:  Wen-Liang Fang; Chew-Wun Wu; Su-Shin Lo; Jen-Hao Chen; Mao-Chih Hsieh; King-Han Shen; Anna Fen-Yau Li; Ling-Chen Tai; Wing-Yiu Lui
Journal:  Hepatogastroenterology       Date:  2009 Jul-Aug

7.  Therapeutic strategy for signet ring cell carcinoma of the stomach.

Authors:  C Kunisaki; H Shimada; M Nomura; G Matsuda; Y Otsuka; H Akiyama
Journal:  Br J Surg       Date:  2004-10       Impact factor: 6.939

8.  Clinicopathology and prognosis of mucinous gastric carcinoma.

Authors:  Shigekazu Hidaka; Kenji Tanaka; Hiroaki Takeshita; Yorihisa Sumida; Hidetoshi Fukuoka; Takafumi Abo; Hiroshi Yano; Atsushi Nanashima; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

9.  Gastric cancer: establishing predictors of biologic behavior with use of population-based data.

Authors:  B J Dicken; L D Saunders; G S Jhangri; C de Gara; C Cass; S Andrews; S M Hamilton
Journal:  Ann Surg Oncol       Date:  2004-05-18       Impact factor: 5.344

10.  The difference in clinic-pathological features between signet ring cell carcinoma and gastric mucinous adenocarcinoma.

Authors:  Hao Jiang; Hongfeng Zhang; Lantian Tian; Xi Zhang; Yingwei Xue
Journal:  Tumour Biol       Date:  2013-05-01
View more
  6 in total

1.  Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component.

Authors:  Ziyu Zhu; Jialiang Gao; Zhixin Liu; Chunfeng Li; Yingwei Xue
Journal:  Biomed Res Int       Date:  2021-05-03       Impact factor: 3.411

2.  Mucinous adenocarcinoma and non-mucinous adenocarcinoma: differing clinicopathological characteristics and computed tomography features in gastric cancer.

Authors:  Jianxi Zhao; Gang Ren; Rong Cai; Jian Chen; Huali Li; Chen Guo; Wenguang He; Xiangru Wu; Wenjie Zhang
Journal:  Oncotarget       Date:  2017-07-11

3.  Prognostic significance of mucinous component in gastric adenocarcinoma after radical D2 gastrectomy.

Authors:  Lei Cai; Yan Li; Xue-Wen Yang; Xiao Lian; Man Guo; Shu-Ao Xiao; Wen-Bin Wang; Hong-Wei Zhang
Journal:  Onco Targets Ther       Date:  2018-02-23       Impact factor: 4.147

4.  Analysis of the Factors Affecting Survival in the Patients who Underwent Curative-Intent Gastrectomy due to Gastric Adenocarcinoma.

Authors:  Serkan Karaisli; Emine Ozlem Gur; Oguzhan Ozsay; Fevzi Cengiz; Ahmet Er; Murat Kemal Atahan; Yasin Peker; Osman Nuri Dilek; Mehmet Haciyanli
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-03-17

5.  Trends of incidence and survival in patients with gastrointestinal mucinous adenocarcinoma.

Authors:  Zhen Zong; Yonghui Luo; Houqun Ying; Anan Wang; Hui Li; Chenghao Yi
Journal:  Oncol Lett       Date:  2018-09-04       Impact factor: 2.967

6.  Prognostic Significance of Signet-Ring Cell Components in Patients With Gastric Carcinoma of Different Stages.

Authors:  Xiaoyuan Dong; Guorui Sun; Hui Qu; Qingsi He; Zhaofan Hao
Journal:  Front Surg       Date:  2021-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.